newsfilter
← Latest News
GlobeNewswire·

ProKidney and Social Capital Suvretta Holdings Corp. III ("SCS") to Host Analyst and Investor Day on April 28, 2022

WINSTON-SALEM, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney) is a leading Phase 3 clinical-stage cellular therapeutics company with Regenerative Medicine Advanced Therapy (RMAT) Designation that has the goal of delaying chronic kidn